Market Research Logo

Ligand Pharmaceuticals Inc (LGND) - Financial and Strategic SWOT Analysis Review

Ligand Pharmaceuticals Inc (LGND) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Ligand Pharmaceuticals Inc (Ligand) develops and acquires technologies that help in discovery and development of medicines. The company employs research technologies including nuclear receptor assays, formulation science, high throughput computer screening, antibody discovery technologies and liver targeted pro-drug technologies to assist companies in securing prescription drug approvals. It provides a diversified portfolio of biotechnology and pharmaceutical products for fungal infections, hepatitis C, Idiopathic thrombocytopenic purpura (ITP), multiple myeloma, cancer, osteoporosis, and severe aplastic anemia. Ligand also offers late-stage development, regulatory management and commercialization support in partnership with other pharmaceutical companies. Ligand is headquartered in San Diego, California, the US.

Ligand Pharmaceuticals Inc Key Recent Developments

May 08,2018: Ligand Reports First Quarter 2018 Financial Results May 8, 2018
Feb 21,2018: Ligand Reports Fourth Quarter and Full Year 2017 Financial Results
Nov 09,2017: Ligand Reports Third Quarter 2017 Financial Results
Aug 29,2017: ImmunoPrecise announces R&D success using the OmniAb® platform to develop fully human antibodies
Aug 21,2017: Ligand Appoints Dr. Nancy Gray to its Board of Directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Ligand Pharmaceuticals Inc - Key Facts
Ligand Pharmaceuticals Inc - Key Employees
Ligand Pharmaceuticals Inc - Key Employee Biographies
Ligand Pharmaceuticals Inc - Major Products and Services
Ligand Pharmaceuticals Inc - History
Ligand Pharmaceuticals Inc - Company Statement
Ligand Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Ligand Pharmaceuticals Inc - Business Description
Ligand Pharmaceuticals Inc - Corporate Strategy
Ligand Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Ligand Pharmaceuticals Inc - Strengths
Ligand Pharmaceuticals Inc - Weaknesses
Ligand Pharmaceuticals Inc - Opportunities
Ligand Pharmaceuticals Inc - Threats
Ligand Pharmaceuticals Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Ligand Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Ligand Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Ligand Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
May 08, 2018: Ligand Reports First Quarter 2018 Financial Results May 8, 2018
Feb 21, 2018: Ligand Reports Fourth Quarter and Full Year 2017 Financial Results
Nov 09, 2017: Ligand Reports Third Quarter 2017 Financial Results
Aug 29, 2017: ImmunoPrecise announces R&D success using the OmniAb® platform to develop fully human antibodies
Aug 21, 2017: Ligand Appoints Dr. Nancy Gray to its Board of Directors
Aug 07, 2017: Ligand Reports Second Quarter 2017 Financial Results
May 09, 2017: Ligand Reports First Quarter 2017 Financial Results
Feb 28, 2017: Ligand Provides Highlights From Analyst Day Event
Feb 23, 2017: Ligand Reports Fourth Quarter and Full Year 2016 Financial Results
Feb 14, 2017: Dr. Christel Iffland Joins Ligand as Vice President, Antibody Technologies, Expands Team Focused on OmniAb Drug Discovery Platform
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Ligand Pharmaceuticals Inc, Key Facts
Ligand Pharmaceuticals Inc, Key Employees
Ligand Pharmaceuticals Inc, Key Employee Biographies
Ligand Pharmaceuticals Inc, Major Products and Services
Ligand Pharmaceuticals Inc, History
Ligand Pharmaceuticals Inc, Subsidiaries
Ligand Pharmaceuticals Inc, Key Competitors
Ligand Pharmaceuticals Inc, Ratios based on current share price
Ligand Pharmaceuticals Inc, Annual Ratios
Ligand Pharmaceuticals Inc, Annual Ratios (Cont...1)
Ligand Pharmaceuticals Inc, Annual Ratios (Cont...2)
Ligand Pharmaceuticals Inc, Interim Ratios
Ligand Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Ligand Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Ligand Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Ligand Pharmaceuticals Inc, Performance Chart (2013 - 2017)
Ligand Pharmaceuticals Inc, Ratio Charts
Ligand Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Ligand Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report